Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
Upstream (Parents) |
---|
(<<) MAGEA3 → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
(<<) MAGEA12 → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
(<<) SLC2A1 → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
(<<) CSAG2///CSAG3 → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
(<<) SPON1 → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
(<<) GOLGA8IP → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
(<<) SLC7A5 → MAGEA2B///MAGEA6///MAGEA3///MAGEA2 |
Downstream (Children) |
---|
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → MAGEA3 (>>) |
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → MAGEA12 (>>) |
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → SRY (>>) |
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → TUBB2B (>>) |
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → CSAG2///CSAG3 (>>) |
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → PLCB1 (>>) |
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → ADAM2 (>>) |
MAGEA2B///MAGEA6///MAGEA3///MAGEA2 → MAGEA4 (>>) |